Name: | Description: | Size: | Format: | |
---|---|---|---|---|
36.62 KB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
Introduction: Selection of first line treatment for patients with metastatic colorectal
cancer (mCRC) is based on tumour and patient related factors. The wide and
increasingly use of targeting agents in this setting are proven to be beneficial in first
line treatment. Increasing evidence suggests that this first line treatment is of great
importance and its impact is being studied in prospective studies. In this retrospective
analysis, we aimed to analyze the first treatment used and its potential impact on
overall survival (OS).
Description
Keywords
Pedagogical Context
Citation
Publisher
Oxford University Press